MPG.eBooks - Search Results

Cover Image

1

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

2

CADTH Canadian drug expert committee recommendation: Erenumab (Aimovig -- Novartis pharmaceuticals Canada Inc.) : indication: prevention of migraine

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

3

CADTH Canadian Drug Expert Committee recommendation: Ofatumumab (Kesimpta -- Novartis Hharmaceuticals Canada Inc.) : indication : multiple sclerosis, relapsing-remitting

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

4

CADTH Canadian drug expert committee recommendation: Vortioxetine (Trintellix --Lundbeck Canada Inc.) : indication: for the treatment of major depressive disorder in adults

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

5

CADTH Canadian Drug Expert Committee recommendation: Icosapent ethyl (Vascepa -- HLS Therapeutics Inc.) : indication : prevention of cardiovascular events in statin-treated patient...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

6

CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

7

CADTH Canadian Drug Expert Committee recommendation: Voretigene neparvovec (Luxturna -- Novartis Pharmaceuticals Canada Inc.) : indication : vision loss, inherited retinal dystroph...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

8

Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

9

CADTH Canadian Drug Expert Committee recommendation: Glyopyrrolate oral solution (Cuvposa -- Medexus Pharmaceuticals, Inc.) : indication: chronic severe drooling, neurologic (pedia...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

10

CADTH Canadian drug expert committee recommendation (final): Certolizumab pegol (Cimzia -- UCB Canada Inc.) : indication : treatment of adult patients with moderate-to severe plaqu...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

11

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

12

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

13

Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

14

CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

15

CADTH Canadian drug expert committee recommendation: Naltrexone hydrochloride and bupropion hydrochloride (Contrave -- Bausch Health, Canada Inc.) : indication: an adjunct to a red...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

16

CADTH Canadian Drug Expert Committee recommendation: Lumacaftor/Ivacaftor (Orkambi -- Vertex Pharmaceuticals (Canada) Incorporated) : indication : cystic fibrosis, F508del-cystic f...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

17

CADTH Canadian Drug Expert Committee Recommendation: Halobetasol propionate and tazarotene (Duobrii -- Bausch Health, Canada Inc.) : indication : psoriasis, moderate to severe plaq...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

18

CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

19

CADTH Canadian drug expert committee recommendation: Cyclosporine 0.1% (Verkazia -- Santen Canada Inc.) : indication : treatment of severe vernal keratoconjunctivitis in children f...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

20

CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

1
2
3
4
5
6
7
8